| Tribenzor for hypertension. | |
| | |
MedLine Citation:
|
PMID: 20814402 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Many patients with hypertension require more than one drug to control their blood pressure.1 Tribenzor (Daiichi Sankyo), recently approved by the FDA for treatment of hypertension, combines the calcium channel blocker amlodipine (Norvasc, and others), the angiotensin receptor blocker (ARB) olmesartan (Benicar) and the most commonly prescribed diuretic, hydrochlorothiazide (HCTZ). Tribenzor is not approved for initial therapy, but is recommended for patients not adequately controlled on any 2-drug combination of a calcium channel blocker, an ARB or a diuretic. |
| | |
Authors:
|
- |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Medical letter on drugs and therapeutics Volume: 52 ISSN: 1523-2859 ISO Abbreviation: Med Lett Drugs Ther Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-03 Completed Date: 2010-10-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985240R Medline TA: Med Lett Drugs Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 70-1 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amlodipine
/
adverse effects,
pharmacology,
therapeutic use* Antihypertensive Agents / adverse effects, pharmacology, therapeutic use* Blood Pressure / drug effects Clinical Trials as Topic Drug Combinations Drug Therapy, Combination Humans Hydrochlorothiazide / adverse effects, pharmacology, therapeutic use* Hypertension / drug therapy*, physiopathology Imidazoles / adverse effects, pharmacology, therapeutic use* Tetrazoles / adverse effects, pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Drug Combinations; 0/Imidazoles; 0/Tetrazoles; 0/Tribenzor; 58-93-5/Hydrochlorothiazide; 88150-42-9/Amlodipine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New treatments for metastic prostate cancer.
Next Document: Multiple-serotype salmonella gastroenteritis outbreak after a reception --- connecticut, 2009.